Abstract: The invention provides an oral solid formulation comprising (a) one or more controlled release components comprising a core comprising levodopa, esters or salts thereof and wherein the one or more controlled release components; and (b) one or more immediate release components comprising levodopa, esters or salts thereof. The oral solid formulation also contains a decarboxylase inhibitor and about 80% to 100% of the decarboxylase inhibitor present in the oral solid formulation is present in the one or more immediate release components.

Abstract: The invention provides an oral solid formulation comprising (a) one or more controlled release components comprising a core comprising levodopa, esters or salts thereof and wherein the one or more controlled release components; and (b) one or more immediate release components comprising levodopa, esters or salts thereof. The oral solid formulation also contains a decarboxylase inhibitor and about 80% to 100% of the decarboxylase inhibitor present in the oral solid formulation is present in the one or more immediate release components.

Abstract: The invention provides an oral solid formulation comprising (a) one or more controlled release components comprising a core comprising levodopa; and (b) one or more immediate release components comprising levodopa. The oral solid formulation also contains a decarboxylase inhibitor wherein the one or more controlled release components are substantially free of the decarboxylase inhibitor.

Abstract: Methods, systems, and apparatus for high-resolution patterning of various substrates with functional materials, including nanomaterials. A technique of preparing a patterned substrate in a high-resolution mold for stick and transfer process is disclosed with promotes integrity of the high-resolution pattern onto the substrate. One example of a substrate is an adhesive tape. The transferred pattern(s) are scalable and can be implemented in different fabrication processes. One example is a roll-to-roll processes. In one embodiment, the transferred pattern comprises nanomaterials and the substrate comprises a flexible substrate for use in flexible and conformal assemblies for a wide variety of applications including, but not limited to, electrical-based sensors on non-planar inanimate surfaces, plant body surface, or human or animal skin.

Abstract: The invention provides an oral solid formulation comprising (a) one or more controlled release components comprising a core comprising levodopa, esters or salts thereof and wherein the one or more controlled release components; and (b) one or more immediate release components comprising levodopa, esters or salts thereof. The oral solid formulation also contains a decarboxylase inhibitor and about 80% to 100% of the decarboxylase inhibitor present in the oral solid formulation is present in the one or more immediate release components.

Abstract: A method of time synchronization between a DS-TT module inside a logical TSN bridge of a communication network with a TSN Grandmaster (GM) in a TSN Time Domain of the communication network. The method comprises, at a NW-TT module inside the logical TSN bridge, determining a frequency rate ratio between a Time Domain clock frequency (f5GS) and a TSN Time Domain clock frequency (fTSN). Then, using the frequency rate ratio and respective times of receipt of a TSN GM synchronization message at an ingress port of the NW-TT module and at an ingress port of the DS-TT module to determine a DS-TT ingress residence time (RDS-TT). Then, using the RDS-TT to synchronize the DS-TT module with the TSN GM.

Abstract: Methods, systems, and apparatus for high-resolution patterning of various substrates with functional materials, including nanomaterials. A technique of preparing a patterned substrate in a high-resolution mold for stick and transfer process is disclosed with promotes integrity of the high-resolution pattern onto the substrate. One example of a substrate is an adhesive tape. The transferred pattern(s) are scalable and can be implemented in different fabrication processes. One example is a roll-to-roll processes. In one embodiment, the transferred pattern comprises nanomaterials and the substrate comprises a flexible substrate for use in flexible and conformal assemblies for a wide variety of applications including, but not limited to, electrical-based sensors on non-planar inanimate surfaces, plant body surface, or human or animal skin.

Abstract: The invention provides an oral solid formulation comprising (a) a controlled release component comprising a core comprising levodopa, wherein the core is coated with a muco-adhesive coating and the muco-adhesive coating is externally coated with an enteric coating; and (b) an immediate release component comprising levodopa. The invention further provides a method for making and using the oral solid formulation.

Abstract: The invention provides an oral solid formulation comprising (a) a controlled release component comprising a core comprising levodopa, wherein the core is coated with a muco-adhesive coating and the muco-adhesive coating is externally coated with an enteric coating; and (b) an immediate release component comprising levodopa. The invention further provides a method for making and using the oral solid formulation.

Abstract: A magnetic material used in the magnetic SF-based composite aerogel is a ferroferric oxide nanocubic particle, which is a magnetic nanomaterial with both excellent magnetocaloric performance and excellent photothermal performance. The magnetic SF-based composite aerogel prepared by the present disclosure exhibits excellent responsiveness to both alternating current (AC) magnetic fields and sunlight. Under an action of an AC magnetic field, the magnetic SF-based composite aerogel exhibits excellent temperature rise performance, which can inhibit the generation of biofouling in pores and channels inside a three-dimensional (3D) porous evaporation material. The magnetic SF-based composite aerogel exhibits excellent water evaporation performance under a sunlight irradiation, with a water evaporation rate of 2.03 kg m?2·h?1.

Abstract: A technique, and its applications, for high resolution, rapid, and simple nanopatterning. The general method has been demonstrated in several forms and applications. One is patterning nanophotonic structures at an optical fiber tip for refractive index sensing. Another is patterning nanoresonator structures on a sensor substrate for plasmonic effect related detection of VOCs. In the latter example, a graphene oxide coated plasmonic crystal as a gas sensor capable of identifying different gas species using an array of such structures. By coating the surface of multiple identical plasmonic crystals with different thicknesses of Graphene-Oxide (GO) layer, the effective refractive index of the GO layer on each plasmonic crystal is differently modulated when exposed to a specific gas. Identification of various gas species is accomplished using pattern recognition algorithm.

Abstract: The invention provides an oral solid formulation comprising (a) a controlled release component comprising a core comprising levodopa, wherein the core is coated with a muco-adhesive coating and the muco-adhesive coating is externally coated with an enteric coating; and (b) an immediate release component comprising levodopa. The invention further provides a method for making and using the oral solid formulation.

Abstract: Described is a method of setting up a direct connection between edge sites on a 5G communications network. The method comprises: configuring 5G network functions (NFs) in the 5G communications network; configuring 5G NFs at the edge sites, if not already configured; and based on said configured NFs, setting up a direct tunnel between the edge sites according to a pre-defined tunnel policy.

Abstract: The invention provides an oral solid formulation comprising (a) a controlled release component comprising a core comprising levodopa, wherein the core is coated with a muco-adhesive coating and the muco-adhesive coating is externally coated with an enteric coating; and (b) an immediate release component comprising levodopa. The invention further provides a method for making and using the oral solid formulation.

Abstract: The invention provides an oral solid formulation comprising (a) a controlled release component comprising a core comprising levodopa, wherein the core is coated with a muco-adhesive coating and the muco-adhesive coating is externally coated with an enteric coating; and (b) an immediate release component comprising levodopa. The invention further provides a method for making and using the oral solid formulation.

Abstract: The present invention discloses a heating shoe, including a sole and a vamp, where the vamp is arranged on the sole; the heating shoe further includes a power supply device, a heating device, and a control device, where an upper surface of the sole is provided with several heating zones, the heating device is electrically connected to the control device, the control device is electrically connected to the power supply device, and the control device is mounted on an outer surface of the vamp; a heating module is arranged on the upper surface of the sole; the heating module includes a plurality of groups of heating elements; a control module independently controls each of the plurality of groups of heating elements; and each of the plurality of groups of heating elements is arranged respectively corresponding to a different one of the heating zones.

Abstract: Described is a method of synchronizing a TSN NW-TT module inside a UPF with a Grandmaster (GM) in a Time Domain of the communication network. The method comprises receiving one or more PTP or gPTP messages on an N3 interface of the UPF. The method includes determining a first time offset value between the GM and the UPF N3 interface based on information received in the PTP or gPTP messages. A timing of the UPF N3 interface is adjusted using the determined first time offset value to synchronize the time between the UPF N3 interface and the GM. The method includes determining a second time offset value between the UPF N3 interface and the NW-TT module. A timing of the NW-TT module is adjusted using the determined second time offset value to synchronize the time between the NW-TT module and the GM.

Abstract: The invention provides an oral solid formulation comprising (a) a controlled release component comprising a core comprising levodopa, wherein the core is coated with a layer of a muco-adhesive polymer and externally coated with a layer of an enteric polymer; and (b) an immediate release component comprising levodopa.

Abstract: Disclosed are Rhodotorula capable of efficiently degrading ethyl carbamate and application thereof, belonging to the technical field of food biotechnology. The present disclosure provides Rhodotorula DL-XSY01 capable of efficiently degrading ethyl carbamate (EC), with a preservation number being CGMCC No. 23534. The Rhodotorula DL-XSY01 is screened, identified, activated, fermented, and embedded to obtain an EC degradation preparation. The strain DL-XSY01 obtained by the present disclosure is prepared into a degradation agent after embedding, which can be used for removing EC in fermented foods. Furthermore, the present disclosure utilizes the degradation agent derived from strain DL-XSY01 to eliminate EC from various food systems. It demonstrates significant EC removal efficacy, low production costs, ease of use, and easy removal from food systems. Thus, it finds wide applicability in fermented foods such as alcoholic beverages, fermented dairy products, soy sauce, and vinegar.

Abstract: A magnetic material used in the magnetic SF-based composite aerogel is a ferroferric oxide nanocubic particle, which is a magnetic nanomaterial with both excellent magnetocaloric performance and excellent photothermal performance. The magnetic SF-based composite aerogel prepared by the present disclosure exhibits excellent responsiveness to both alternating current (AC) magnetic fields and sunlight. Under an action of an AC magnetic field, the magnetic SF-based composite aerogel exhibits excellent temperature rise performance, which can inhibit the generation of biofouling in pores and channels inside a three-dimensional (3D) porous evaporation material. The magnetic SF-based composite aerogel exhibits excellent water evaporation performance under a sunlight irradiation, with a water evaporation rate of 2.03 kg m?2·h?1.